Citrate Buffer Solution 0.09 M

<strong>Citrate Buffer Solution 0.09 M</strong>_x000D_ <strong>Catalog number:</strong> B2016265_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Citrate Buffer Solution, 0.09 M_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid Hemodial Int. 2013 Apr;17(2):313-20._x000D_ 2: Li J, Chatterjee K, Medek A, Shalaev E, Zografi G. Acid-base characteristics of bromophenol blue-citrate buffer systems in the amorphous state J Pharm Sci. 2004 Mar;93(3):697-712._x000D_ 3: Islam MR. Can potassium citrate replace sodium bicarbonate and potassium chloride of oral rehydration solution? Arch Dis Child. 1985 Sep;60(9):852-5._x000D_ 4: Nurmohamed SA, Jallah BP, Vervloet MG, Yldirim G, ter Wee PM, Groeneveld AB. Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study BMC Nephrol. 2013 Apr 18;14:89._x000D_ 5: Richtrova P, Mares J, Kielberger L, Trefil L, Eiselt J, Reischig T. Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility Artif Organs. 2017 Aug;41(8):759-766._x000D_ 6: Gao F, Matsuya S, Ohta M, Zhang J. Erosion process of light-cured and conventional glass ionomer cements in citrate buffer solution Dent Mater J. 1997 Dec;16(2):170-9._x000D_ 7: Lew SQ, Kohn OF, Cheng YL, Kjellstrand CM, Ing TS. Three-Stream, Bicarbonate-Based Hemodialysis Solution Delivery System Revisited: With an Emphasis on Some Aspects of Acid-Base Principles Artif Organs. 2017 Jun;41(6):509-518._x000D_ 8: Mandolfo S, Borlandelli S, Elli A. Catheter lock solutions: it's time for a change J Vasc Access. 2006 Jul-Sep;7(3):99-102._x000D_ 9: Abdel Azim ABE, ElSaid TW, El Said HW, Hemida W, Zaghlool S, Ramadan A, Gouda Z, El Masry S, Reda W, Ali HM. A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients
 Clin Nephrol. 2018 Nov;90(5):341-349._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34558319">10: Bodega-Azuara J, Bellés-Medall MD, Edo-Peñarrocha J, Ferrando-Piqueres R, Perez-Alba A, Reque-Santivañez J. Vancomycin and daptomycin stability in heparin or sodium citrate lock solutions J Vasc Access. 2023 Jul;24(4):696-701. </a>_x000D_ _x000D_ <strong>Products Related to Citrate Buffer Solution 0.09 M can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>